When you receive a prostate cancer diagnosis, you need the best, most innovative treatments and internationally recognized clinician-scientists by your side. City of Hope is a National Cancer Institute-designated comprehensive cancer center with multiple Orange County locations ready to treat your prostate cancer.
The City of Hope Difference: Prostate Cancer Care
City of Hope is a National Cancer Institute-designated comprehensive cancer center that offers Orange County residents exceptional prostate cancer expertise and leading-edge prostate cancer treatments.
Next-generation genetic screening and prevention programs
Precision medicine and targeted therapies
Minimally invasive surgical techniques
Clinical trials of groundbreaking new treatments
For more than a decade, U.S. News & World Report has named City of Hope one of the top cancer hospitals in America. Our highly specialized clinicians and scientists are focused solely on cancer, rapidly turning our innovative research into advanced treatments for patients across Orange County and beyond.
Renowned Physicians and Researchers
Every year, thousands of people facing prostate cancer, from stage 1 to stage 4, are successfully treated at City of Hope. Our patients’ five-year survival rate is very close to 100%.
Our interdisciplinary team works with you to develop an individualized and highly coordinated treatment plan based on your unique needs.
City of Hope Orange County is the only cancer center in the region offering the gold standard of prostate cancer testing known as targeted, transparent perineal prostate biopsies. By combining this biopsy with sophisticated MRI technology, City of Hope Orange County can increase the accuracy of detecting abnormalities in the prostate, reducing the likelihood of false negatives and the need for subsequent biopsies.
Listen to Our Prostate Cancer Specialists and Patients
Dr. Cory Hugen, M.D. M.S. is a renowned urologic researcher and clinician. He has been the lead or co-investigator on dozens of clinical trials in addition to being a multi-decorated physician serving in the United States Air Force.
Misagh Karimi, M.D., a physician with two decades' experience, says he chose oncology because it's a fast-paced, constantly-evolving field with many exciting new developments. As of 2020, Dr. Karimi has relocated to City of Hope's Newport Beach Clinic.
Sandy Liu, M.D., has made it her mission to improve the lives of cancer patients by taking care of people in a meaningful way and advancing the field of medical oncology as a clinical researcher. She makes sure to treat all of her patients as though they were members of her own family.
Sumanta (Monty) Kumar Pal, M.D., FASCO, is an internationally recognized leader in the area of genitourinary cancers, including kidney, bladder, and prostate cancer. He is co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution.
Nishan Tchekmedyian, M .D., has been recognized by Greater Newport Physicians, a group that named him New Physician of the Year in 2017 and Specialist of the Year in 2019, 2020 and 2021 for his high-quality, patient-focused care.
Jeffrey S. Yoshida, M.D. recognizes that each of his patients carries a unique personality and background - as does their cancer. For that reason, he believes that medical care should be customized and specific to the individual.
We Specialize in State-of-the-Art Treatments
Our advanced cancer treatments include:
City of Hope is a leader in minimally invasive, robotically assisted prostatectomies, which use a surgical robot and smaller incisions to remove the diseased prostate and surrounding tissue
Image-guided external radiation systems, including TomoTherapy and TrueBeam combine detailed imaging and radiation delivery technologies, allowing our care team to “sculpt” radiation beams to the tumor site while avoiding nearby healthy tissue
MRI-guided focused ultrasound, a non-radiation technology, uses magnetic resonance imaging (MRI) to detail images of the prostate area, followed by highly focused ultrasound to heat up and destroy cancerous tissue
Brachytherapy places radioactive material next to or within the tumor site. Depending on the cancer stage, your needs and treatment goals, radioactive material may be low-dose and permanently placed (low dose rate / LDR brachytherapy) or high-dose and placed for only a few minutes (high dose rate / HDR brachytherapy)
Hormone therapy blocks production or activity of hormones – particularly testosterone and dihydrotestosterone (DHT) which fuel most prostate cancer growth
Chemotherapy targets all rapidly dividing cells, including prostate cancer cells
Targeted therapy selectively attacks prostate cancer cells based on specific characteristics – such as a gene mutation
Immunotherapy stimulates your immune system to attack cancer cells
Active surveillance is effective for early-stage, slow-growing prostate cancers. This approach includes regular monitoring of prostate-specific antigen (PSA) levels and digital rectal examinations of the prostate. If abnormalities or symptoms arise, you and your physician can discuss treating the cancer
Access to a wide variety of clinical trials, including new chemotherapy and targeted therapies, hormone therapies with fewer side effects, novel surgical techniques, innovative radiation approaches and new prevention strategies
Expert and compassionate care through our City of Hope network, including City of Hope Orange County Lennar Foundation Cancer Center and five network locations in Irvine Sand Canyon, Newport Beach, Huntington Beach, Long Beach and Torrance.